Radiation therapy in the era of immune treatment for hepatocellular carcinoma

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment in recent years and provide new opportunities to treat hepatocellular carcinoma (HCC). To date, several ICIs have been approved by the FDA for advanced HCC in first-line or second-line therapy. Downstaging conversion therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lingjuan, Zhang, Ruiguang, Lin, Zhenyu, Tan, Qiaoyun, Huang, Zhiyong, Liang, Binyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895775/
https://www.ncbi.nlm.nih.gov/pubmed/36742293
http://dx.doi.org/10.3389/fimmu.2023.1100079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895775/
https://www.ncbi.nlm.nih.gov/pubmed/36742293
http://dx.doi.org/10.3389/fimmu.2023.1100079

Ejemplares similares